Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00019721 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: MART-1 antigen
BIOLOGICAL: aldesleukin
BIOLOGICAL: gp100 antigen
BIOLOGICAL: incomplete Freund's adjuvant

Sponsor

National Cancer Institute (NCI)